Several experimental prostate cancer drugs have produced striking results in early-stage clinical trials, with at least one ...

Amanda Peet detailed her recent breast cancer diagnosis in a new essay, sharing that her health battle coincided with both of ...

Simone Boseman reflected on her late husband Chadwick Boseman’s colon cancer battle, over five years after his death in 2020: “We both felt very sure that he would make it through.” ...

Top experts share the latest bladder, kidney and prostate cancer advances from the 2026 ASCO GU Symposium, highlighting patient impact. At the 2026 ASCO GU meeting, experts gathered to share the ...

Researchers presented clinical study results on the dual-tracer PET imaging technique at the European urology conference with peer-reviewed publication forthcoming.

Detailed price information for Lantheus Holdings (LNTH-Q) from The Globe and Mail including charting and trades.

A discussion with the patient about the importance of bone health when treated with androgen-deprivation therapy (ADT) should occur early in the treatment plan. Daniel P. Petrylak, MD, of the Yale ...

Clarity Pharmaceuticals (ASX: CU6) ("Clarity" or "Company"), a clinical-stage radiopharmaceutical company with a mission to develop next-generation products that improve treatment outcomes for ...

Tagawa, MD, identified 3 primary clinical scenarios where PSMA PET scans have become the established standard for prostate cancer care. The first application is initial s ...

Prostate-specific membrane androgen PET/CT can help clinicians intensify or de-escalate care for men with prostate cancer who have biochemical recurrence following radical prostatectomy.A ...

Sudden, unexplained bone breaks could be a sign of cancer. Even though most low-trauma fractures come from osteoporosis or falls, certain cancers can weaken bones. Doctor stresses that fractures out ...

The 2026 European Association of Urology (EAU) annual meeting featured a plenary prostate cancer session and a presentation by Dr. Jozefina Casuscelli discussing the optimal management of de-novo ...